CoChat
Sign Up
Cited by 168Allergic Rhinitis and SensitizationAsthma and respiratory diseasesFood Allergy and Anaphylaxis Research

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Open access
Bousquet, Jean, Schünemann, Holger J., Hellings, Peter W., Arnavielhe, Sylvie, Bachert, Claus, Bedbrook, Anna, Bergmann, Karl-Christian, Bosnic-Anticevich, Sinthia, Brozek, Jan, Calderon, Moises, Canonica, G. Walter, Casale, Thomas B., Chavannes, Niels H., Cox, Linda, Chrystyn, Henry, Cruz, Alvaro A., Dahl, Ronald, De Carlo, Giuseppe, Demoly, Pascal, Devillier, Phillipe, Dray, Gérard, Fletcher, Monica, Fokkens, Wytske J., Fonseca, Joao, Gonzalez-Diaz, Sandra N., Grouse, Lawrence, Keil, Thomas, Kuna, Piotr, Larenas-Linnemann, Désirée, Lodrup Carlsen, Karin C., Meltzer, Eli O., Mullol, Jaoquim, Muraro, Antonella, Naclerio, Robert N., Palkonen, Susanna, Papadopoulos, Nikolaos G., Passalacqua, Giovanni, Price, David, Ryan, Dermot, Samolinski, Boleslaw, Scadding, Glenis K., Sheikh, Aziz, Spertini, François, Valiulis, Arunas, Valovirta, Erkka, Walker, Samantha, Wickman, Magnus, Yorgancioglu, Arzu, Haahtela, Tari, Zuberbier, Torsten, Aberer, Werner, Adachi, Mitsuru, Agache, Ioana, Akdis, Cezmi, Akdis, Mubeccel, Annesi-Maesano, Isabella, Ansotegui, Ignacio J., Anto, Josep M., Arshad, S. Hasan, Baiardini, Ilaria, Baigenzhin, Abay K., Barbara, Cristina, Bateman, Eric D., Beghé, Bianca, Bel, Elisabeth H., Ben Kheder, Ali, Bennoor, Kazi S., Benson, Michael, Bernstein, David, Michael, Bewick, Thomas, Bieber, Bindslev-Jensen, Carsten, Bjermer, Leif, Blain, Hubert, Boner, Attilio, Bonini, Matteo, Bonini, Sergio, Bosse, Isabelle, Bouchard, Jacques, Boulet, Louis-Philippe, Bourret, Rodolphe A., Bousquet, Philippe J., Braido, Fulvio, Briggs, Andrew H., Brightling, Christopher E., Buhl, Roland, Burney, Peter, Bush, Andrew, Caballero-Fonseca, Fernando, Caimmi, Davide P., Camargos, Paulo, Camuzat, Thierry, Carlsen, Kai-Hakon, Carr, Warner, Casale, Thomas B., Sarabia, Alfonso Cepeda, Chatzi, Leda, Chen, Yuzhi, Chiron, Raphaël, Chkhartishvili, Ekaterine, Chuchalin, Alexander, Ciprandi, Georgio, Cirule, Ieva, Correia de Sousa, Jaime, Costa, David, Crooks, George, Custovic, Adnan, Dahlen, Sven-Erik, Darsow, Ulf, De Blay, Frédéric, De Manuel Keenoy, Esteban, Dedeu, Tony, Deleanu, Diana, Denburg, Judah, Didier, Alain, Dinh-Xuan, Anh-Tuan, Dokic, Dejan, Douagui, Habib B., Dubakiene, Ruta, Durham, Stephen, Dykewicz, Mark, El-Gamal, Yehia, Emuzyte, Regina, Fink-Wagner, Antje, Fiocchi, Alessandro, Forastiere, Francesco, Gamkrelidze, Amiran, Gemicioğlu, Bilun, Gereda, Jose E., Gerth van Wijk, Roy, Gotua, Maia, Grisle, Ineta, Guzmán, M. Antonieta, Haahtela, Tari, Heinrich, Joachim, Hellquist-Dahl, Birthe, Horak, Friedrich, Howarth, Peter H., Humbert, Marc, Hyland, Michael, Ivancevich, Juan-Carlos, Jares, Edgardo J., Johnston, Sebastian L., Jonquet, Olivier, Joos, Guy, Jung, Ki-Suck, Just, Jocelyne, Jutel, Marek, Kaidashev, Igor P., Khaitov, Musa, Kalayci, Omer, Kalyoncu, Fuat, Keith, Paul, Khaltaev, Nikolai, Kleine-Tebbe, Jorg, Klimek, Ludger, N'Goran, Bernard Koffi, Kolek, Vitezlav, Koppelman, Gerard H., Kowalski, Marek, Kull, Inger, Kvedariene, Violeta, Lambrecht, Bart, Lau, Susanne, Laune, Daniel, Le Thi Tuyet, Lan, Li, Jing, Lieberman, Phillipe, Lipworth, Brian J., Renaud, Louis, Magard, Yves, Magnan, Antoine, Mahboub, Bassam, Majer, Ivan, Makela, Mika, Manning, Peter J., Masjedi, Mohamad R., Maurer, Marcus, Mavale-Manuel, Sandra, Melén, Erik, Melo-Gomes, Elisabete, Mercier, Jacques, Merk, Hans, Miculinic, Neven, Mihaltan, Florin, Milenkovic, Branislava, Mohammad, Yousser, Molimard, Mathieu, Momas, Isabelle, Montilla-Santana, Anna, Morais-Almeida, Mario, Mösges, Ralph, Nadif, Rachel, Namazova-Baranova, Leyla, Neffen, Hugo, Nekam, Kristof, Neou, Angelos, Niggemann, Bodo, Nyembue, Dieudonné, O'Hehir, Robyn, Ohta, Ken, Okamoto, Yoshitaka, Okubo, Kim, Ouedraogo, Solange, Paggiaro, Pier-Luigi, Pali-Schöll, Isabella, Palmer, Stephen, Panzner, Petr, Papi, Alberto, Park, Hae-Sim, Pavord, Ian, Pawankar, Ruby, Pfaar, Oliver, Picard, Robert, Pigearias, Bernard, Pin, Isabelle, Plavec, Davor, Pohl, Wolfgang, Popov, Todor, Postma, Dirkje S., Potter, Paul, Poulsen, Lars K., Rabe, Klaus F., Raciborski, Filip, Pontal, Françoise Radier, Reitamo, Sakari, Repka-Ramirez, Maria-Susana, Robalo-Cordeiro, Carlos, Roberts, Graham, Rodenas, Francisco, Rolland, Christine, Rodriguez, Miguel Roman, Romano, Antonino, Rosado-Pinto, José, Rosario, Nelson A., Rosenwasser, Larry, Rottem, Menachem, Sanchez-Borges, Mario, Sastre-Dominguez, Joaquim, Schmid-Grendelmeier, Peter, Serrano, Eli, Simons, F. Estelle R., Sisul, Juan-Carlos, Skrindo, Ingebjorg, Smit, Henriette A., Solé, Dirceu, Sooronbaev, Talant, Spranger, Otto, Stelmach, Rafael, Strandberg, Timo, Sunyer, Jordi, Thijs, Carel, Todo-Bom, Ana-Maria, Triggiani, Massimo, Valenta, Rudolf, Valero, Antonio L., van Hage, Marianne, Vandenplas, Olivier, Vezzani, Giorgio, Vichyanond, Pakit, Viegi, Giovanni, Wagenmann, Martin, Wahn, Ulrich, De Yun, Wang, Williams, Denis, Wright, John, Yawn, Barbara P., Yiallouros, Panayiotis, Yusuf, Osman M., Zar, Heather J., Zernotti, Mario, Zhang, Luo, Zhong, Nanshan, Zidarn, Mihaela·2016·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2016.03.025
Open this paper in CoChat — free accountOpen PDF

Abstract

The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2016.03.025

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The efficacy of MP-AzeFlu is superior to intranasal corticosteroids and intranasal H1 antihistamine monotherapy in patients with moderate-severe, poorly controlled allergic rhinitis or nonallergic rhinitis.

    “The efficacy of MP-AzeFlu has been shown to be superior to INCs and intranasal anti-H 1 monotherapy in patients with moderate-severe, poorly controlled AR or NAR [148-150].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [150]

    Box 1 (PATIENTS' VIEWS; page unavailable) says that combined intranasal fluticasone and azelastine is more effective than either monotherapy when treatment for allergic rhinitis is inadequate. The ALGORITHM DECISION AID recommends the combination for allergic rhinitis that remains uncontrolled, but our copy does not establish the claimed superiority in nonallergic rhinitis. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 99

  1. Meltzer, 2013, Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions, Allergy Asthma Proc, 34, 301, 10.2500/aap.2013.34.3676 · DOI
  2. Bousquet, 2015, MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation, Allergy, 70, 1372, 10.1111/all.12686 · DOI
  3. Berlin, 2006, A taxonomic description of computer-based clinical decision support systems, J Biomed Inform, 39, 656, 10.1016/j.jbi.2005.12.003 · DOI · Paper page
  4. Bourret, 2013, An integrated approach to telemonitoring noncommunicable diseases: best practice from the European innovation partnership on active and healthy ageing, World Hosp Health Serv, 49, 25
  5. Bousquet, 2016, AIRWAYS ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation, Eur Respir J, 47, 1028, 10.1183/13993003.01856-2015 · DOI
  6. Bousquet, 2013, [The French reference sites of the European Innovation Partnership on active and healthy ageing], Presse Med, 42, 1558, 10.1016/j.lpm.2013.11.002 · DOI
  7. Bousquet, 2014, Integrated care pathways for airway diseases (AIRWAYS-ICPs), Eur Respir J, 44, 304, 10.1183/09031936.00014614 · DOI
  8. 2007, Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007, J Allergy Clin Immunol, 120, S94
  9. O'Byrne, 2010, Measuring asthma control: a comparison of three classification systems, Eur Respir J, 36, 269, 10.1183/09031936.00124009 · DOI
  10. Reddel, 2015, A summary of the new GINA strategy: a roadmap to asthma control, Eur Respir J, 46, 622, 10.1183/13993003.00853-2015 · DOI
  11. Thomas, 2011, Approaches to stepping up and stepping down care in asthmatic patients, J Allergy Clin Immunol, 128, 915, 10.1016/j.jaci.2011.07.014 · DOI
  12. Patel, 2013, Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?, Expert Rev Respir Med, 7, 451, 10.1586/17476348.2013.837777 · DOI
  13. Bousquet, 2010, Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma, J Allergy Clin Immunol, 126, 926, 10.1016/j.jaci.2010.07.019 · DOI · Paper page
  14. Bousquet, 2012, Severe chronic allergic (and related) diseases: a uniform approach—a MeDALL—GA2LEN—ARIA position paper, Int Arch Allergy Immunol, 158, 216, 10.1159/000332924 · DOI
  15. Schatz, 2010, Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control, Ann Allergy Asthma Immunol, 104, 118, 10.1016/j.anai.2009.11.063 · DOI
  16. Demoly, 2011, Validation of a self-questionnaire for assessing the control of allergic rhinitis, Clin Exp Allergy, 41, 860, 10.1111/j.1365-2222.2011.03734.x · DOI
  17. Nolte, 2006, Unawareness and undertreatment of asthma and allergic rhinitis in a general population, Respir Med, 100, 354, 10.1016/j.rmed.2005.05.012 · DOI
  18. Vuurman, 2014, Allergic rhinitis is a risk factor for traffic safety, Allergy, 69, 906, 10.1111/all.12418 · DOI
  19. Hellgren, 2010, Allergic rhinitis and the common cold—high cost to society, Allergy, 65, 776, 10.1111/j.1398-9995.2009.02269.x · DOI · Paper page
  20. Zuberbier, 2014, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Allergy, 69, 1275, 10.1111/all.12470 · DOI
  21. Lamb, 2006, Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective, Curr Med Res Opin, 22, 1203, 10.1185/030079906X112552 · DOI · Paper page
  22. Walker, 2007, Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study, J Allergy Clin Immunol, 120, 381, 10.1016/j.jaci.2007.03.034 · DOI · Paper page
  23. Bousquet, 2010, Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial, J Allergy Clin Immunol, 126, 666, 10.1016/j.jaci.2010.06.034 · DOI
  24. Demoly, 2013, Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis, Clin Exp Allergy, 43, 881, 10.1111/cea.12121 · DOI
  25. Ohta, 2013, Visual analog scale as a predictor of GINA-defined asthma control. The SACRA study in Japan, J Asthma, 50, 514, 10.3109/02770903.2013.786726 · DOI
  26. Padjas, 2014, Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study, J Allergy Clin Immunol, 133, 777, 10.1016/j.jaci.2013.08.029 · DOI
  27. Scadding, 2008, BSACI guidelines for the management of allergic and non-allergic rhinitis, Clin Exp Allergy, 38, 19, 10.1111/j.1365-2222.2007.02888.x · DOI
  28. Wallace, 2008, The diagnosis and management of rhinitis: an updated practice parameter, J Allergy Clin Immunol, 122, S1, 10.1016/j.jaci.2008.06.003 · DOI · Paper page
  29. Brozek, 2010, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision, J Allergy Clin Immunol, 126, 466, 10.1016/j.jaci.2010.06.047 · DOI · Paper page
  30. Roberts, 2013, Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology, Allergy, 68, 1102, 10.1111/all.12235 · DOI · Paper page
  31. Scadding, 2015, Optimal management of allergic rhinitis, Arch Dis Child, 100, 576, 10.1136/archdischild-2014-306300 · DOI
  32. Larenas-Linnemann, 2014, [ARIA Mexico 2014. Adaptation of the Clinical Practice Guide ARIA 2010 for Mexico. Methodology ADAPTE], Rev Alerg Mex, 61, S3, 10.29262/ram.v61i0.52 · DOI
  33. Seidman, 2015, Clinical practice guideline: allergic rhinitis executive summary, Otolaryngol Head Neck Surg, 152, 197, 10.1177/0194599814562166 · DOI · Paper page
  34. Hampel, 2010, Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device, Ann Allergy Asthma Immunol, 105, 168, 10.1016/j.anai.2010.06.008 · DOI
  35. Carr, 2012, A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis, J Allergy Clin Immunol, 129, 1282, 10.1016/j.jaci.2012.01.077 · DOI · Paper page
  36. Fokkens, 2007, Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen, Allergy, 62, 1078, 10.1111/j.1398-9995.2007.01522.x · DOI
  37. Bielory, 2011, Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis, Allergy, 66, 686, 10.1111/j.1398-9995.2010.02543.x · DOI
  38. Anolik, 2008, Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis, Ann Allergy Asthma Immunol, 100, 264, 10.1016/S1081-1206(10)60452-8 · DOI
  39. Esteitie, 2010, Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis, Ann Allergy Asthma Immunol, 105, 155, 10.1016/j.anai.2010.05.017 · DOI
  40. Castillo, 2015, Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis, Cochrane Database Syst Rev, 6, CD009566
  41. Meltzer, 2013, Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis, Int Arch Allergy Immunol, 161, 369, 10.1159/000351404 · DOI
  42. Church, 2010, Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper, Allergy, 65, 459, 10.1111/j.1398-9995.2009.02325.x · DOI · Paper page
  43. Wang, 2015, Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps, J Allergy Clin Immunol, 135, 922, 10.1016/j.jaci.2014.10.018 · DOI
  44. Mullol, 2015, Update on rupatadine in the management of allergic disorders, Allergy, 70, 1, 10.1111/all.12531 · DOI
  45. Matricardi, 2011, Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses, J Allergy Clin Immunol, 128, 791, 10.1016/j.jaci.2011.03.049 · DOI
  46. Devillier, 2014, A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis, BMC Med, 12, 71, 10.1186/1741-7015-12-71 · DOI
  47. Jutel, 2015, International consensus on allergy immunotherapy, J Allergy Clin Immunol, 136, 556, 10.1016/j.jaci.2015.04.047 · DOI
  48. Marple, 2007, Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction, Otolaryngol Head Neck Surg, 136, S107
  49. Ciprandi, 2011, Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey, Curr Med Res Opin, 27, 1005, 10.1185/03007995.2011.559580 · DOI
  50. Frati, 2014, A survey of clinical features of allergic rhinitis in adults, Med Sci Monit, 20, 2151, 10.12659/MSM.891206 · DOI
  51. Turner, 2013, Validation of the allergic rhinitis treatment satisfaction and preference scale, Allergy Asthma Proc, 34, 551, 10.2500/aap.2013.34.3715 · DOI
  52. Baena-Cagnani, 2015, The international survey on the management of allergic rhinitis by physicians and patients (ISMAR), World Allergy Organ J, 8, 10, 10.1186/s40413-015-0057-0 · DOI
  53. Demoly, 2015, Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index—the benefica study, Allergy Asthma Clin Immunol, 11, 8, 10.1186/s13223-015-0073-1 · DOI
  54. Fromer, 2014, Current Allergic Rhinitis Experiences Survey (CARES): consumers' awareness, attitudes and practices, Allergy Asthma Proc, 35, 307, 10.2500/aap.2014.35.3766 · DOI
  55. Zicari, 2013, A survey on features of allergic rhinitis in children, Curr Med Res Opin, 29, 415, 10.1185/03007995.2013.779238 · DOI
  56. Demoly, 2014, Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response, Allergy Asthma Clin Immunol, 10, 29, 10.1186/1710-1492-10-29 · DOI
  57. Virchow, 2011, Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients—an observational, cross sectional study in four countries in Europe, J Med Econ, 14, 305, 10.3111/13696998.2011.576039 · DOI
  58. Valovirta, 2008, The voice of the patients: allergic rhinitis is not a trivial disease, Curr Opin Allergy Clin Immunol, 8, 1, 10.1097/ACI.0b013e3282f3f42f · DOI
  59. Hellings, 2012, Explorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis, Clin Transl Allergy, 2, 9, 10.1186/2045-7022-2-9 · DOI
  60. Green, 2007, Concerns of patients with allergic rhinitis: the Allergic Rhinitis Care Programme in South Africa, Prim Care Respir J, 16, 299, 10.3132/pcrj.2007.00062 · DOI
  61. Bousquet, 2009, Unmet needs in severe chronic upper airway disease (SCUAD), J Allergy Clin Immunol, 124, 428, 10.1016/j.jaci.2009.06.027 · DOI
  62. Hellings, 2013, Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?, Allergy, 68, 1, 10.1111/all.12040 · DOI
  63. Mullol, 2013, Specialist-based treatment reduces the severity of allergic rhinitis, Clin Exp Allergy, 43, 723, 10.1111/cea.12081 · DOI
  64. Todd, 1996, Clinical significance of reported changes in pain severity, Ann Emerg Med, 27, 485, 10.1016/S0196-0644(96)70238-X · DOI
  65. Kelly, 1998, Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?, Acad Emerg Med, 5, 1086, 10.1111/j.1553-2712.1998.tb02667.x · DOI
  66. Gallagher, 2001, Prospective validation of clinically important changes in pain severity measured on a visual analog scale, Ann Emerg Med, 38, 633, 10.1067/mem.2001.118863 · DOI
  67. Gallagher, 2002, Reliability and validity of a visual analog scale for acute abdominal pain in the ED, Am J Emerg Med, 20, 287, 10.1053/ajem.2002.33778 · DOI
  68. Lee, 2003, Clinically important change in the visual analog scale after adequate pain control, Acad Emerg Med, 10, 1128, 10.1197/S1069-6563(03)00372-5 · DOI
  69. Jensen, 2003, Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain, J Pain, 4, 407
  70. Auffinger, 2013, Measuring surgical outcomes in cervical spondylotic myelopathy patients undergoing anterior cervical discectomy and fusion: assessment of minimum clinically important difference, PLoS One, 8, e67408, 10.1371/journal.pone.0067408 · DOI
  71. Bourdel, 2015, Systematic review of endometriosis pain assessment: how to choose a scale?, Hum Reprod Update, 21, 136, 10.1093/humupd/dmu046 · DOI
  72. Khanna, 2008, The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice, J Rheumatol, 35, 2339, 10.3899/jrheum.080375 · DOI
  73. Kelly, 2001, The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain, Emerg Med J, 18, 205, 10.1136/emj.18.3.205 · DOI · Paper page
  74. Myles, 1999, The pain visual analog scale: is it linear or nonlinear?, Anesth Analg, 89, 1517, 10.1213/00000539-199912000-00038 · DOI
  75. Bird, 2001, Clinically significant changes in pain along the visual analog scale, Ann Emerg Med, 38, 639, 10.1067/mem.2001.118012 · DOI
  76. Emshoff, 2011, Clinically important difference thresholds of the visual analog scale: a conceptual model for identifying meaningful intraindividual changes for pain intensity, Pain, 152, 2277, 10.1016/j.pain.2011.06.003 · DOI
  77. Bijur, 2001, Reliability of the visual analog scale for measurement of acute pain, Acad Emerg Med, 8, 1153, 10.1111/j.1553-2712.2001.tb01132.x · DOI
  78. DeLoach, 1998, The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale, Anesth Analg, 86, 102
  79. Kersten, 2012, The use of the Visual Analogue Scale (VAS) in rehabilitation outcomes, J Rehabil Med, 44, 609, 10.2340/16501977-0999 · DOI
  80. Demoly, 2013, Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis, Clin Exp Allergy, 43, 881, 10.1111/cea.12121 · DOI
  81. Bousquet, 2013, Impact of allergic rhinitis symptoms on quality of life in primary care, Int Arch Allergy Immunol, 160, 393, 10.1159/000342991 · DOI · Paper page
  82. Bousquet, 2009, Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis, J Allergy Clin Immunol, 123, 1349, 10.1016/j.jaci.2009.02.033 · DOI
  83. Azevedo, 2013, Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care, Prim Care Respir J, 22, 112, 10.4104/pcrj.2013.00012 · DOI
  84. Fonseca, 2010, Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma, Allergy, 65, 1042, 10.1111/j.1398-9995.2009.02310.x · DOI · Paper page
  85. Bousquet, 2010, Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial, J Allergy Clin Immunol, 126, 666, 10.1016/j.jaci.2010.06.034 · DOI
  86. van der Leeuw, 2015, The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts, NPJ Prim Care Respir Med, 25, 14107, 10.1038/npjpcrm.2014.107 · DOI
  87. Klimek, 2015, Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study, Allergy Asthma Proc, 36, 40, 10.2500/aap.2015.36.3823 · DOI
  88. Morais-Almeida, 2013, Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study, Allergy, 68, 1278, 10.1111/all.12221 · DOI
  89. Morais-Almeida, 2013, Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal, Allergy, 68, 1150, 10.1111/all.12207 · DOI
  90. Bousquet, 2009, Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study, Allergy, 64, 1516, 10.1111/j.1398-9995.2009.02115.x · DOI
  91. Bousquet, 2010, Efficacy of desloratadine in persistent allergic rhinitis—a GA(2)LEN study, Int Arch Allergy Immunol, 153, 395, 10.1159/000316351 · DOI
  92. Ohta, 2011, Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan, Allergy, 66, 1287, 10.1111/j.1398-9995.2011.02676.x · DOI · Paper page
  93. Larenas-Linnemann, 2013, Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico, Am J Rhinol Allergy, 27, 495, 10.2500/ajra.2013.27.3957 · DOI
  94. Shao, 2014, Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis, Am J Rhinol Allergy, 28, 131, 10.2500/ajra.2014.28.4006 · DOI
  95. Wei, 2013, Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis, Int J Med Sci, 10, 1914, 10.7150/ijms.7117 · DOI
  96. Tatar, 2012, Is there any correlation between the results of skin-prick test and the severity of symptoms in allergic rhinitis?, Am J Rhinol Allergy, 26, e37, 10.2500/ajra.2012.26.3750 · DOI
  97. Bousquet, 2007, ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France, Int Arch Allergy Immunol, 143, 163, 10.1159/000099307 · DOI
  98. del Cuvillo, 2010, Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients—the ADRIAL cohort study, Rhinology, 48, 201
  99. Rouve, 2010, Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity, Rhinology, 48, 285, 10.4193/Rhino09.208 · DOI

Cited by

Sorted by citations

Authors
Bousquet, J., Schünemann, H. J., Hellings, P. W., Arnavielhe, S., Bachert, C., Bedbrook, A., Bergmann, K.-C., Bosnic-Anticevich, S., Brozek, J., Calderon, M., Canonica, G. W., Casale, T. B., Chavannes, N. H., Cox, L., Chrystyn, H., Cruz, A. A., Dahl, R., De Carlo, G., Demoly, P., Devillier, P., Dray, G., Fletcher, M., Fokkens, W. J., Fonseca, J., Gonzalez-Diaz, S. N., Grouse, L., Keil, T., Kuna, P., Larenas-Linnemann, D., Lodrup Carlsen, K. C., Meltzer, E. O., Mullol, J., Muraro, A., Naclerio, R. N., Palkonen, S., Papadopoulos, N. G., Passalacqua, G., Price, D., Ryan, D., Samolinski, B., Scadding, G. K., Sheikh, A., Spertini, F., Valiulis, A., Valovirta, E., Walker, S., Wickman, M., Yorgancioglu, A., Haahtela, T., Zuberbier, T., Aberer, W., Adachi, M., Agache, I., Akdis, C., Akdis, M., Annesi-Maesano, I., Ansotegui, I. J., Anto, J. M., Arshad, S. H., Baiardini, I., Baigenzhin, A. K., Barbara, C., Bateman, E. D., Beghé, B., Bel, E. H., Ben Kheder, A., Bennoor, K. S., Benson, M., Bernstein, D., Michael, B., Thomas, B., Bindslev-Jensen, C., Bjermer, L., Blain, H., Boner, A., Bonini, M., Bonini, S., Bosse, I., Bouchard, J., Boulet, L.-P., Bourret, R. A., Bousquet, P. J., Braido, F., Briggs, A. H., Brightling, C. E., Buhl, R., Burney, P., Bush, A., Caballero-Fonseca, F., Caimmi, D. P., Camargos, P., Camuzat, T., Carlsen, K.-H., Carr, W., Casale, T. B., Sarabia, A. C., Chatzi, L., Chen, Y., Chiron, R., Chkhartishvili, E., Chuchalin, A., Ciprandi, G., Cirule, I., Correia de Sousa, J., Costa, D., Crooks, G., Custovic, A., Dahlen, S.-E., Darsow, U., De Blay, F., De Manuel Keenoy, E., Dedeu, T., Deleanu, D., Denburg, J., Didier, A., Dinh-Xuan, A.-T., Dokic, D., Douagui, H. B., Dubakiene, R., Durham, S., Dykewicz, M., El-Gamal, Y., Emuzyte, R., Fink-Wagner, A., Fiocchi, A., Forastiere, F., Gamkrelidze, A., Gemicioğlu, B., Gereda, J. E., Gerth van Wijk, R., Gotua, M., Grisle, I., Guzmán, M. A., Haahtela, T., Heinrich, J., Hellquist-Dahl, B., Horak, F., Howarth, P. H., Humbert, M., Hyland, M., Ivancevich, J.-C., Jares, E. J., Johnston, S. L., Jonquet, O., Joos, G., Jung, K.-S., Just, J., Jutel, M., Kaidashev, I. P., Khaitov, M., Kalayci, O., Kalyoncu, F., Keith, P., Khaltaev, N., Kleine-Tebbe, J., Klimek, L., N'Goran, B. K., Kolek, V., Koppelman, G. H., Kowalski, M., Kull, I., Kvedariene, V., Lambrecht, B., Lau, S., Laune, D., Le Thi Tuyet, L., Li, J., Lieberman, P., Lipworth, B. J., Renaud, L., Magard, Y., Magnan, A., Mahboub, B., Majer, I., Makela, M., Manning, P. J., Masjedi, M. R., Maurer, M., Mavale-Manuel, S., Melén, E., Melo-Gomes, E., Mercier, J., Merk, H., Miculinic, N., Mihaltan, F., Milenkovic, B., Mohammad, Y., Molimard, M., Momas, I., Montilla-Santana, A., Morais-Almeida, M., Mösges, R., Nadif, R., Namazova-Baranova, L., Neffen, H., Nekam, K., Neou, A., Niggemann, B., Nyembue, D., O'Hehir, R., Ohta, K., Okamoto, Y., Okubo, K., Ouedraogo, S., Paggiaro, P.-L., Pali-Schöll, I., Palmer, S., Panzner, P., Papi, A., Park, H.-S., Pavord, I., Pawankar, R., Pfaar, O., Picard, R., Pigearias, B., Pin, I., Plavec, D., Pohl, W., Popov, T., Postma, D. S., Potter, P., Poulsen, L. K., Rabe, K. F., Raciborski, F., Pontal, F. R., Reitamo, S., Repka-Ramirez, M.-S., Robalo-Cordeiro, C., Roberts, G., Rodenas, F., Rolland, C., Rodriguez, M. R., Romano, A., Rosado-Pinto, J., Rosario, N. A., Rosenwasser, L., Rottem, M., Sanchez-Borges, M., Sastre-Dominguez, J., Schmid-Grendelmeier, P., Serrano, E., Simons, F. E. R., Sisul, J.-C., Skrindo, I., Smit, H. A., Solé, D., Sooronbaev, T., Spranger, O., Stelmach, R., Strandberg, T., Sunyer, J., Thijs, C., Todo-Bom, A.-M., Triggiani, M., Valenta, R., Valero, A. L., van Hage, M., Vandenplas, O., Vezzani, G., Vichyanond, P., Viegi, G., Wagenmann, M., Wahn, U., De Yun, W., Williams, D., Wright, J., Yawn, B. P., Yiallouros, P., Yusuf, O. M., Zar, H. J., Zernotti, M., Zhang, L., Zhong, N., & Zidarn, M.
Affiliations
  • Inserm (FR)
  • McMaster University (CA)
  • KU Leuven (BE)
  • Ghent University Hospital (BE)
  • Charité – Universitätsmedizin Berlin (DE)
  • The University of Sydney (AU)
  • Ospedale Policlinico San Martino (IT)
  • Leiden University Medical Center (NL)
  • Nova Southeastern University (US)
  • Odense University Hospital (DK)
  • IMT Mines Alès (FR)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • University of Washington (US)
  • University of Würzburg (DE)
  • Medical University of Lodz (PL)
  • Allergy and Asthma Medical Group and Research Center (US)
  • Azienda Ospedale - Università Padova (IT)
  • European Federation of Allergy and Airways Diseases Patients Associations (BE)
  • National and Kapodistrian University of Athens (GR)
  • University of Aberdeen (GB)
  • University of Edinburgh (GB)
  • Medical University of Warsaw (PL)
  • University College London (GB)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of Turku (FI)
  • Asthma UK (GB)
  • Karolinska Institutet (SE)
  • Vilnius University (LT)
  • Université de Versailles Saint-Quentin-en-Yvelines (FR)
  • University of Chicago (US)
Corresponding author
Bousquet, Jean
ORCID
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2016-08
Volume
138
Issue
2
Pages
367-374.e2
ISSN
0091-6749 (ISSN-L)
DOI
10.1016/j.jaci.2016.03.025
OpenAlex
W2416946533
Cited by
168
References
5
Citations by year
2026: 5 · 2025: 7 · 2024: 11 · 2023: 8 · 2022: 9 · 2021: 19 · 2020: 29 · 2019: 29 · 2018: 22 · 2017: 24 · 2016: 5
FWCI
3.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc-nd)
  • Pure Amsterdam UMC (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • Research Explorer (The University of Manchester) (publishedVersion, cc-by-nc-nd)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, cc-by-nc-nd)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (publishedVersion, cc-by-nc-nd)
  • SERVAL (Université de Lausanne) (publishedVersion, other-oa)
  • El Repositorio Academico Digital de la UANL (Universidad Autónoma de Nuevo León) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • HAL (submittedVersion, cc-by)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
  • IRIS (submittedVersion)
  • Lirias (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc-nd)
  • Site cant be reached (submittedVersion, cc-by-nc-nd)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by-nc-nd)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by-nc-nd)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Amgen
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • World Health Organization
  • Teva Pharmaceutical Industries
  • University of Chicago
  • Regeneron Pharmaceuticals
  • Respiratory Effectiveness Group
  • Mylan
  • Glenmark Pharmaceuticals
  • British Lung Foundation
  • European Commission
  • Department of Science and Technology, Ministry of Science and Technology, India
  • European Academy of Allergy and Clinical Immunology
  • Allergopharma
  • Medical Research Council
  • Efficacy and Mechanism Evaluation Programme
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Keywords
allergic rhinitis, clinical decision support systems, treatment algorithm, drug selection, disease control, adolescents, adults, active and healthy ageing, consensus algorithms
MeSH terms
Clinical Decision-Making, Adolescent, Adult, Age Factors, Algorithms, Conjunctivitis, Allergic, Humans, Patient Satisfaction, Disease Management, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review